Your browser doesn't support javascript.
loading
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling.
Singh, Kirit; Hotchkiss, Kelly M; Parney, Ian F; De Groot, John; Sahebjam, Solmaz; Sanai, Nader; Platten, Michael; Galanis, Evanthia; Lim, Michael; Wen, Patrick Y; Minniti, Giuseppe; Colman, Howard; Cloughesy, Timothy F; Mehta, Minesh P; Geurts, Marjolein; Arrillaga-Romany, Isabel; Desjardins, Annick; Tanner, Kirk; Short, Susan; Arons, David; Duke, Elizabeth; Wick, Wolfgang; Bagley, Stephen J; Ashley, David M; Kumthekar, Priya; Verhaak, Roel; Chalmers, Anthony J; Patel, Anoop P; Watts, Colin; Fecci, Peter E; Batchelor, Tracy T; Weller, Michael; Vogelbaum, Michael A; Preusser, Matthias; Berger, Mitchel S; Khasraw, Mustafa.
Afiliação
  • Singh K; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
  • Hotchkiss KM; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
  • Parney IF; Mayo Clinic, Rochester, MN, USA.
  • De Groot J; Division of Neuro-Oncology, Department of Neurological Surgery, University of California San Francisco (UCSF), San Francisco, CA, USA.
  • Sahebjam S; National Institute of Health, Bethesda, MD, USA.
  • Sanai N; Ivy Brain Tumor Center, The Barrow Neurological Institute, Phoenix, AZ, USA.
  • Platten M; Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
  • Galanis E; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Lim M; Mayo Clinic, Rochester, MN, USA.
  • Wen PY; Department of Neurosurgery, Stanford University, School of Medicine, Stanford, CA, USA.
  • Minniti G; Center for Neuro-Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Colman H; Department of Radiological Sciences, Oncology and Anatomical Pathology, Sapienza University of Rome, Rome, Italy.
  • Cloughesy TF; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Mehta MP; Neuro-Oncology Program, University of California Los Angeles (UCLA), Los Angeles, CA, USA.
  • Geurts M; Miami Cancer Institute, Miami, FL, USA.
  • Arrillaga-Romany I; Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Desjardins A; Massachusetts General Hospital, Boston, MA, USA.
  • Tanner K; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
  • Short S; National Brain Tumor Society (NBTS), Newton, MA, USA.
  • Arons D; School of Medicine, University of Leeds, Leeds, UK.
  • Duke E; National Brain Tumor Society (NBTS), Newton, MA, USA.
  • Wick W; US Food and Drug Administration, Silver Spring, MD, USA.
  • Bagley SJ; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Ashley DM; Department of Neurooncology, Heidelberg University, Heidelberg, Germany.
  • Kumthekar P; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Verhaak R; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
  • Chalmers AJ; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Patel AP; School of Medicine, Yale University, New Haven, CT, USA.
  • Watts C; School of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Fecci PE; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
  • Batchelor TT; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Weller M; Surgical Neuro-Oncology, Department of Neurology, Duke University Medical Center, Durham, NC, USA.
  • Vogelbaum MA; Brigham and Women's Hospital, Boston, MA, US.
  • Preusser M; Department of Neurology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Berger MS; Department of NeuroOncology, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, USA.
  • Khasraw M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
Nat Med ; 29(10): 2402-2405, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37488293
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Limite: Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Limite: Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos